Mangalam Drugs and Organics Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Mangalam Drugs and Organics Ltd. on BSE

Search Inside the pdf :

Mangalam Drugs and Organics Ltd.

30 May 2025

79.70

-0.16%

Company Update

Mangalam Drugs & Organics Ltd - 532637 - Board Meeting Outcome for Revised Outcome Of Board …

BSE India

Revised outcome of Board Meeting held on 17th May, 2025 inter-alia to approve Audited Financial Results for the quarter and year ended 31st March, 2025.

pdf

Mangalam Drugs and Organics Ltd.

19 May 2025

79.70

-0.16%

Company Update

Mangalam Drugs & Organics Ltd - 532637 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper publication for Declaration of financial results for the quarter and year ended 31st March, 2025

pdf

Mangalam Drugs and Organics Ltd.

17 May 2025

79.70

-0.16%

Result

Mangalam Drugs & Organics Ltd - 532637 - Approval Of Financial Results For The Quarter And …

BSE India

Outcome of board meeting held on 17th May, 2025 for approval of Audited Financial Results for the quarter ended 31st, March, 2025

pdf

	Mar 2025	Dec 2024	Mar 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	73.25	88.85	102.28	-17.6%	-28.4%
Operating Profit Qtr	10.16	8.77	11.70	15.8%	-13.2%
Net Profit Qtr	0.06	1.29	3.53	-95.3%	-98.3%
Earning Per Share Adjusted latest Qtr	0.04	0.81	2.23	-95.1%	-98.2%

* Consolidated data

Detailed Results

Mangalam Drugs and Organics Ltd.

17 May 2025

79.70

-0.16%

Board Meeting

Mangalam Drugs & Organics Ltd - 532637 - Board Meeting Outcome for Outcome Of Board Meeting …

BSE India

Outcome of Board meeting held on 17th May, 2025 at 5:00 p.m. to approve Audited Financial Results of the Company for the quarter and year ended 31st March 2025

pdf

Mangalam Drugs and Organics Ltd.

14 May 2025

79.70

-0.16%

Board Meeting

Mangalam Drugs & Organics Ltd - 532637 - Board Meeting Intimation for Approval Of Audited Financial …

BSE India

Mangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2025 ,inter alia, to consider and approve Intimation of Board meeting to be held on 17th May, 2025 inter-alia to approve Audited Financial Results(standalone and consolidated) for the quarter and year ended 31st March, 2025.

pdf

Mangalam Drugs and Organics Ltd.

11 Apr 2025

79.70

-0.16%

Company Update

Mangalam Drugs & Organics Ltd - 532637 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Outcome of Board meeting held on 11th April, 2025 inter alia for approval of appointment of Chief Financial Officer (Key Managerial Personal) of the Company w.e.f. 11th April , 2025.

pdf

Mangalam Drugs and Organics Ltd.

11 Apr 2025

79.70

-0.16%

Board Meeting

Mangalam Drugs & Organics Ltd - 532637 - Board Meeting Outcome for Outcome Of Board Meeting …

BSE India

Outcome of Board meeting held on Friday, 11th April, 2025 at 2:00 P.M. inter alia, for approval of following Businesses: Appointment of Chief Financial Officer , Internal Auditor, Cost Auditor of the Company.

pdf

Mangalam Drugs and Organics Ltd.

09 Apr 2025

79.70

-0.16%

Company Update

Mangalam Drugs & Organics Ltd - 532637 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) …

BSE India

Certificate under Regulation 74(5) of SEBI (Depositories Participants) Regulations, 2018 received from MUFG Intime India Private Limited (previously Link Intime India Private Limited)-RTA on 5th April 2025

pdf

Mangalam Drugs and Organics Ltd.

07 Apr 2025

79.70

-0.16%

Company Update

Mangalam Drugs & Organics Ltd - 532637 - Regulatory Update As Per Regulation 31(4) Of Substantial …

BSE India

Regulatory update as per Regulation 31(4) of Substantial Acquisition of shares and Takeover Regulations, 2011

pdf

Mangalam Drugs and Organics Ltd.

04 Apr 2025

79.70

-0.16%

Board Meeting

Mangalam Drugs & Organics Ltd - 532637 - Board Meeting Intimation for Intimation Of Board Meeting …

BSE India

Mangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/04/2025 ,inter alia, to consider and approve Intimation of Board Meeting to be held on 11th April, 2025 for approval of appointment of Chief Financial Officer of the Company w.e.f. 11th April, 2025.

pdf

Is Mangalam Drugs and Organics Ltd. worth buying?

99 Votes:

Buy 78.79%

Sell 15.15%

Hold 6.06%